JPWO2020022507A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020022507A5 JPWO2020022507A5 JP2020532517A JP2020532517A JPWO2020022507A5 JP WO2020022507 A5 JPWO2020022507 A5 JP WO2020022507A5 JP 2020532517 A JP2020532517 A JP 2020532517A JP 2020532517 A JP2020532517 A JP 2020532517A JP WO2020022507 A5 JPWO2020022507 A5 JP WO2020022507A5
- Authority
- JP
- Japan
- Prior art keywords
- benzyloxyphenylthio
- chlorophenyl
- diol
- propane
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018141411 | 2018-07-27 | ||
| JP2018141411 | 2018-07-27 | ||
| JP2019036598 | 2019-02-28 | ||
| JP2019036598 | 2019-02-28 | ||
| PCT/JP2019/029524 WO2020022507A1 (ja) | 2018-07-27 | 2019-07-26 | 造血幹細胞移植を受けた患者における血液悪性腫瘍の再発抑制剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020022507A1 JPWO2020022507A1 (ja) | 2021-08-05 |
| JPWO2020022507A5 true JPWO2020022507A5 (https=) | 2022-07-28 |
| JP7389486B2 JP7389486B2 (ja) | 2023-11-30 |
Family
ID=69181631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020532517A Active JP7389486B2 (ja) | 2018-07-27 | 2019-07-26 | 造血幹細胞移植を受けた患者における血液悪性腫瘍の再発抑制剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210283073A1 (https=) |
| EP (1) | EP3831370A4 (https=) |
| JP (1) | JP7389486B2 (https=) |
| KR (1) | KR102948053B1 (https=) |
| CN (2) | CN112512516A (https=) |
| AU (1) | AU2019311609B2 (https=) |
| BR (1) | BR112021001376A2 (https=) |
| IL (1) | IL280451B2 (https=) |
| MX (1) | MX2021001039A (https=) |
| TW (1) | TWI899057B (https=) |
| WO (1) | WO2020022507A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022162409A1 (en) | 2021-01-28 | 2022-08-04 | Priothera Sas | Methods of treatment with s1p receptor modulators |
| AU2022214268A1 (en) | 2021-01-28 | 2023-07-27 | Priothera Limited | Methods of treatment with s1p receptor modulators |
| EP4282407A1 (en) | 2022-05-27 | 2023-11-29 | Priothera SAS | Treatment of cancer with s1p receptor agonists |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2461212C (en) | 2001-09-27 | 2010-08-17 | Kyorin Pharmaceutical Co., Ltd. | Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same |
| DE60235900D1 (de) | 2001-09-27 | 2010-05-20 | Kyorin Seiyaku Kk | Osuppressivum |
| US7781617B2 (en) * | 2004-07-16 | 2010-08-24 | Kyorin Pharmaceutical Co., Ltd | Effective use method of medicaments and method of preventing expression of side effect |
| EP1806338B1 (en) | 2004-10-12 | 2016-01-20 | Kyorin Pharmaceutical Co., Ltd. | Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride and hydrates thereof. and intermediates the production thereof |
| PL1932522T3 (pl) | 2005-10-07 | 2012-09-28 | Kyorin Seiyaku Kk | Środek terapeutyczny do leczenia choroby wątroby zawierający jako składnik czynny pochodną 2-amino-1,3-propanodiolu |
| TWI389683B (zh) | 2006-02-06 | 2013-03-21 | Kyorin Seiyaku Kk | A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient |
| EP2252615A1 (en) * | 2008-01-25 | 2010-11-24 | Arena Pharmaceuticals, Inc. | Dihydro- 1h- pyrrolo [1,2-a]indol-1-yl carboxylic derivatives which act as s1p1 agonists |
| US10407727B2 (en) * | 2013-01-30 | 2019-09-10 | Memorial Sloan Kettering Cancer Center | Donor KIR3DL1 and HLA-B subtypes and leukemia control in HLA-compatible allogenic hematopoietic stem cell transplantation |
| BR112015019197A2 (pt) * | 2013-02-20 | 2017-07-18 | Kyorin Seiyaku Kk | tratamento de doença de enxerto versus hospedeiro em pacientes transplantados |
| US10154989B2 (en) * | 2015-09-17 | 2018-12-18 | Emory University | Methods of managing graft versus host disease (GvHD) using indole carboxyaldehydes or derivatives thereof |
| ES2917208T3 (es) | 2016-03-08 | 2022-07-07 | Priothera Ltd | Tratamiento de pacientes con trasplante de células madre hematopoyéticas |
-
2019
- 2019-07-26 IL IL280451A patent/IL280451B2/en unknown
- 2019-07-26 TW TW108126590A patent/TWI899057B/zh active
- 2019-07-26 EP EP19842105.9A patent/EP3831370A4/en active Pending
- 2019-07-26 KR KR1020217002596A patent/KR102948053B1/ko active Active
- 2019-07-26 WO PCT/JP2019/029524 patent/WO2020022507A1/ja not_active Ceased
- 2019-07-26 JP JP2020532517A patent/JP7389486B2/ja active Active
- 2019-07-26 CN CN201980050102.5A patent/CN112512516A/zh active Pending
- 2019-07-26 BR BR112021001376-8A patent/BR112021001376A2/pt unknown
- 2019-07-26 MX MX2021001039A patent/MX2021001039A/es unknown
- 2019-07-26 AU AU2019311609A patent/AU2019311609B2/en active Active
- 2019-07-26 CN CN202510467128.7A patent/CN120284929A/zh active Pending
- 2019-07-26 US US17/263,440 patent/US20210283073A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023041862A5 (https=) | ||
| CN114008035A (zh) | 一种shp2磷酸酶变构抑制剂 | |
| Zorzi et al. | A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium | |
| JP2009545620A5 (https=) | ||
| ZA202202361B (en) | Treatment of hidradenitis suppurativa using jak inhibitors | |
| JPWO2020022507A5 (https=) | ||
| RU2012148710A (ru) | Органическое соединение для применения при лечении рака печени | |
| JP2019515909A5 (https=) | ||
| JP2025508004A5 (https=) | ||
| JP2023541432A5 (https=) | ||
| JP2023541766A5 (https=) | ||
| JP2007520506A5 (https=) | ||
| JP2019508476A5 (https=) | ||
| JP2023535744A5 (https=) | ||
| JP2016509050A5 (https=) | ||
| JP2019526559A5 (https=) | ||
| CN115916778A (zh) | 甲硫氨酸腺苷转移酶抑制剂、其制备方法及应用 | |
| CL2024003601A1 (es) | Nuevas combinaciones terapéuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2020529995A5 (https=) | ||
| JP2005508896A5 (https=) | ||
| JP2012525358A5 (https=) | ||
| TWI899057B (zh) | 接受造血幹細胞移植的患者之血液惡性腫瘤的復發抑制劑 | |
| WO2004043336A3 (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases | |
| IL275091B2 (en) | Methods for treating gaucher disease | |
| JP2024522163A5 (https=) |